These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33910705)

  • 41. Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".
    Pozdzik A; Maalouf N; Letavernier E; Brocheriou I; Body JJ; Vervaet B; Van Haute C; Noels J; Gadisseur R; Castiglione V; Cotton F; Gambaro G; Daudon M; Sakhaee K
    J Nephrol; 2019 Oct; 32(5):681-698. PubMed ID: 30680550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary stone risk factors in the descendants of patients with kidney stone disease.
    Dissayabutra T; Kalpongkul N; Rattanaphan J; Boonla C; Srisa-Art M; Ungjaroenwathana W; Tosukhowong P
    Pediatr Nephrol; 2018 Jul; 33(7):1173-1181. PubMed ID: 29594505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Single Nucleotide Polymorphism (rs4236480) in TRPV5 Calcium Channel Gene Is Associated with Stone Multiplicity in Calcium Nephrolithiasis Patients.
    Khaleel A; Wu MS; Wong HS; Hsu YW; Chou YH; Chen HY
    Mediators Inflamm; 2015; 2015():375427. PubMed ID: 26089600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion.
    Dimke H; Desai P; Borovac J; Lau A; Pan W; Alexander RT
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F761-9. PubMed ID: 23283989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heritable traits that contribute to nephrolithiasis.
    Lieske JC; Wang X
    Urolithiasis; 2019 Feb; 47(1):5-10. PubMed ID: 30460525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis.
    van der Wijst J; van Goor MK; Schreuder MF; Hoenderop JG
    Kidney Int; 2019 Dec; 96(6):1283-1291. PubMed ID: 31471161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrolithiasis and nephrocalcinosis in cerebrotendinous xanthomatosis: report of three siblings.
    Chang WN; Cheng YF
    Eur Neurol; 1995; 35(1):55-7. PubMed ID: 7737249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients.
    Ferreira LG; Pereira AC; Heilberg IP
    Nephron Clin Pract; 2010; 114(2):c135-44. PubMed ID: 19887834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of renal papillae in kidney stone formers.
    Marien TP; Miller NL
    Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial aggregation of renal calcium stone disease.
    Trinchieri A; Mandressi A; Luongo P; Coppi F; Pisani E
    J Urol; 1988 Mar; 139(3):478-81. PubMed ID: 3343730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tubular and genetic disorders associated with kidney stones.
    Mohebbi N; Ferraro PM; Gambaro G; Unwin R
    Urolithiasis; 2017 Feb; 45(1):127-137. PubMed ID: 27896392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms.
    Gambaro G; Vezzoli G; Casari G; Rampoldi L; D'Angelo A; Borghi L
    Am J Kidney Dis; 2004 Dec; 44(6):963-86. PubMed ID: 15558518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.
    Tang X; Bergstralh EJ; Mehta RA; Vrtiska TJ; Milliner DS; Lieske JC
    Kidney Int; 2015 Mar; 87(3):623-31. PubMed ID: 25229337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Calcium kidney stones. Diagnostic and preventive prospects].
    Arcidiacono T; Terranegra A; Biasion R; Soldati L; Vezzoli G
    G Ital Nefrol; 2007; 24(6):535-46. PubMed ID: 18278757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathophysiology and diagnosis of nephrocalcinosis].
    Fuster D
    Ther Umsch; 2007 May; 64(5):287-90. PubMed ID: 17685089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.
    Guerra A; Ticinesi A; Allegri F; Nouvenne A; Pinelli S; Folesani G; Lauretani F; Maggio M; Borghi L; Meschi T
    Urolithiasis; 2016 Nov; 44(6):521-528. PubMed ID: 27038481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. X-linked recessive nephrolithiasis: presentation and diagnosis in children.
    Schurman SJ; Norden AG; Scheinman SJ
    J Pediatr; 1998 May; 132(5):859-62. PubMed ID: 9602200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease.
    Denburg MR; Koepsell K; Lee JJ; Gerber J; Bittinger K; Tasian GE
    J Am Soc Nephrol; 2020 Jun; 31(6):1358-1369. PubMed ID: 32381601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary causes of kidney stones and chronic kidney disease.
    Edvardsson VO; Goldfarb DS; Lieske JC; Beara-Lasic L; Anglani F; Milliner DS; Palsson R
    Pediatr Nephrol; 2013 Oct; 28(10):1923-42. PubMed ID: 23334384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.